HERG

Results: 73



#Item
41Microsoft Word - CCCA5AC4.doc

Microsoft Word - CCCA5AC4.doc

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-01-05 16:25:57
42ICH S7B Guideline Step 2 Revision The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals

ICH S7B Guideline Step 2 Revision The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-09-10 06:20:27
43Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-10-17 17:52:11
44Microsoft Word - 04D-0378-EC3-Attach-2.doc

Microsoft Word - 04D-0378-EC3-Attach-2.doc

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-01-05 16:25:58
45inical Evaluation of QT Prolongati 0 Docket 04D-0377, ICH El Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation Page 14

inical Evaluation of QT Prolongati 0 Docket 04D-0377, ICH El Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation Page 14

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-01-05 16:25:54
46Genes in Long QT Syndromes Andrew D. Krahn MD FRCPC Coworkers: Michael Gollob MD* George J. Klein MD

Genes in Long QT Syndromes Andrew D. Krahn MD FRCPC Coworkers: Michael Gollob MD* George J. Klein MD

Add to Reading List

Source URL: www.sads.ca

Language: English - Date: 2013-03-10 20:04:19
47INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL

Add to Reading List

Source URL: www.ich.org

Language: English - Date: 2012-06-22 05:08:05
48Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-13 08:05:27
49Heart Rhythm[removed], 60 – 64  www.heartrhythmjournal.com Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome

Heart Rhythm[removed], 60 – 64 www.heartrhythmjournal.com Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome

Add to Reading List

Source URL: www.sads.org

Language: English - Date: 2010-07-30 19:42:54
50DCRP consult  to evaluate  nonclinical cardiac safety data  for propoxyphene (January 21, 2010 memo)

DCRP consult to evaluate nonclinical cardiac safety data for propoxyphene (January 21, 2010 memo)

Add to Reading List

Source URL: www.fda.gov

Language: English